Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

SodaStream International Ltd (SODA) Got Hosed

Page 1 of 2

Once again, another blowout quarter by SodaStream International Ltd (NASDAQ:SODA) was squandered.

The company that has turned tens of millions of consumers into home-based makers of soft drinks posted another fizzy fiscal performance last week. The market didn’t care. Shares of SodaStream slumped 7% last week, dropping all three trading days since Wednesday morning’s report.

Where did the pop star go wrong? Let’s go over three potential shortcomings.

Sodastream International Ltd (NASDAQ:SODA)Profitability is just a number
Some sites claim that SodaStream missed Wall Street’s profit target. Bottom-line trackers were expecting profitability to climb from $0.32 a share a year earlier to $0.39 a share this holiday quarter. SodaStream’s reported profit of $0.36 a share did fall short, but the company’s guidance and Wall Street’s forecasts are based on adjusted earnings. SodaStream actually earned $0.45 a share on that basis.

How do we know that analysts are basing their estimates on the adjusted figure? Well, a year earlier SodaStream’s reported profitability was just $0.26 a share. The adjusted figure of $0.32 a share is what the profit trackers were pitting the company against last week.

No monster under that bed.

Do the sequential slide in consumption
Another possible sticking point rests in the sequential dip in consumables. SodaStream did sell a record 1.1 million starter kits on the way to a 55% surge in revenue, but the number of carbonators clocked in flat sequentially and soda flavor bottles actually dipped between the third and fourth quarters.

Oops? Nope.

This is a seasonal business. Folks don’t slurp down as much soda when the weather starts to get chilly. Don’t just take it from SodaStream. The Coca-Cola Company (NYSE:KO) went from posting $12.34 billion in net operating revenue during last year’s third quarter to just $11.46 billion during the fourth quarter. On a year-over-year basis, SodaStream’s CO2 refills and syrups were up 26% and 60%, respectively.

The actual soda maker systems may have spiked to a new record given the holiday period, but it will be later in the year when consumers are truly getting busy with the fizzy. There was a slight sequential uptick in consumables in 2011 between the third and fourth quarters, but the number of carbonators declined sequentially between the third and fourth quarters of 2010.

There’s no monster under that bed, either.

View from the carbonated crow’s nest
SodaStream’s guidance calls for revenue and adjusted earnings to climb 25% in 2013.

This may have seemed problematic on the surface. Analysts were targeting growth spurts of 20% in revenue but 28% in earnings per share.

Was SodaStream’s outlook mixed? No. Analysts were expecting a profit of $2.74 a share in 2013 based on 2012 starting lines that proved to be woefully short of reality. SodaStream generated far more in adjusted earnings and revenue than Mr. Market was expecting, and 25% growth on the bottom line in 2013 will actually be well north of $2.74 a share.

In fact, in just three trading days since SodaStream’s report, the average analyst profit target has increased from $2.74 a share to $2.78 a share. Wall Street’s revenue forecast has gone from $510.2 million to $522.7 million in those same three days, and both targets should continue to inch higher as analysts update their numbers to match SodaStream’s own outlook, which would be $545.4 million in revenue and closer to $3 a share in profitability.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!